The largest database of trusted experimental protocols

4 protocols using observer z1 inverted fluorescence microscope

1

Neutrophil NET Release Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils were treated with OptiMEM media as a no treatment (NT) control, untreated FM-CM (FM); LPS-stimulated FM-CM (FM+LPS); or LPS alone (1ng/ml) for 5 mins to 3 hrs at 37°C. As a positive control in some cases, treatment with phorbol myristate acetate (PMA, 100nM) was included. NET release was quantified by measuring dsDNA release into culture supernatants using the Quant-iT PicoGreen dsDNA assay (Thermo Fisher Scientific, Waltham, MA), and fluorescence measured at 485/535nm using the Tecan Infinite M1000 Pro microplate reader (Thermo Fisher Scientific). NET release was also visualized by immunofluorescence as follows. Extracellular DNA was stained using Sytox Green (167nM, Thermo Fisher Scientific) or Hoechst (1μg/ml, Life technologies). Cells were then fixed in 4% paraformaldehyde (PFA) before staining with antibodies against citrullinated histone 3 (#ab5103, 1:100 dilution, Abcam, Cambridge, UK) and/or neutrophil elastase (#ab21595, 1:100 dilution, Abcam). Primary antibody binding was detected using the Alexa Fluor 564-labelled anti-rabbit antibody (1:500 dilution, Thermo Fisher Scientific). Cells were viewed using the Observer Z1 inverted fluorescence microscope (Zeiss, Thornwood, NY). Images were captured by the Volocity software (PerkinElmer, Waltham, MA) and merged on ImageJ (31 (link)).
+ Open protocol
+ Expand
2

In Vivo Biodistribution and Tumor Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
SCC7 tumor-bearing mice were developed by injecting 2 ​× ​106 ​cells in 30 ​μL of saline subcutaneously into the left thigh of C3H/HeN mice. When the tumor size reached 200–250 ​mm3, 100 ​μL of the sample solution was administered via the tail vein. Whole-body biodistribution was observed at 3, 6, 12, and 24 ​h after the injection of the samples using IVIS Lumina XRMS (PerkinElmer, Inc., Waltham, MA, USA). At each time point, 30 ​μL of blood was collected from the tail vein, and the fluorescence imaging was performed by an IVIS system. At the last time point, the tumor and major organs (heart, lung, liver, spleen, and kidney) were dissected, and ex vivo fluorescence images were obtained by IVIS. IVIS imaging was performed at a wavelength of Cy5.5. The dissected tumors were fixed in 4% paraformaldehyde for 24 ​h and treated with increasing concentrations from 10% sucrose to 20% sucrose. Then, tumor tissues were frozen in optimal cutting temperature (OCT) compound and sectioned at 10 ​μm thickness. Sectioned tissues were attached to glass slides and dried. The tissues were washed several times in PBS and counterstained with 2 ​μg/mL of Hoechst 33,342 for 20 ​min at room temperature. The fluorescence from the tissue was observed in an Observer. Z1 inverted fluorescence microscope (Carl Zeiss, Jena, Germany).
+ Open protocol
+ Expand
3

Quantifying Astrocyte Proliferation via BrdU

Check if the same lab product or an alternative is used in the 5 most similar protocols
Puromycin-selected lentivirus-transduced primary astrocytes from both KD and control groups were incubated in medium with the BrdU labeling reagent (Thermo Fisher Scientific) for 60 min and were subsequently fixed with 70% ethanol for 20 min at RT. After washing three times with PBS, cells were treated with 1.5M HCl (Sigma-Aldrich) for 30 min and were stained with mouse BrdU antibody (Cell Signaling), Alexa Fluor 488-conjugated goat anti-mouse IgG (H+L) antibody (Invitrogen), and DAPI. Three independent incubations were carried out and results were obtained by counting from 10 random fields for each experiment. Images were captured using a Zeiss Observer Z1 inverted fluorescence microscope at 20x magnification.
+ Open protocol
+ Expand
4

Quantifying Astrocyte Proliferation via BrdU

Check if the same lab product or an alternative is used in the 5 most similar protocols
Puromycin-selected lentivirus-transduced primary astrocytes from both KD and control groups were incubated in medium with the BrdU labeling reagent (Thermo Fisher Scientific) for 60 min and were subsequently fixed with 70% ethanol for 20 min at RT. After washing three times with PBS, cells were treated with 1.5M HCl (Sigma-Aldrich) for 30 min and were stained with mouse BrdU antibody (Cell Signaling), Alexa Fluor 488-conjugated goat anti-mouse IgG (H+L) antibody (Invitrogen), and DAPI. Three independent incubations were carried out and results were obtained by counting from 10 random fields for each experiment. Images were captured using a Zeiss Observer Z1 inverted fluorescence microscope at 20x magnification.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!